Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy

scientific article published on 02 February 2014

Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.UROLONC.2013.11.010
P698PubMed publication ID24495451

P50authorShahrokh ShariatQ7462263
Marek BabjukQ12035273
Tobias KlatteQ88250588
Morgan RouprêtQ88883209
Pierre I KarakiewiczQ97332033
Evanguelos XylinasQ101135017
Malte RiekenQ114316459
Harun FajkovicQ114316461
Yair LotanQ61862568
P2093author name stringChristian Seitz
Michela de Martino
P2860cites workLoss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO geneQ81725657
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patientsQ84072813
Prognostic markers for urothelial cancer: obstacles and opportunitiesQ84483420
Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network DatabaseQ84883989
Cancer statistics, 2013Q27860762
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancerQ33783766
What a difference 2 nucleotides make: a short review of ABO geneticsQ36190639
ABO blood group and breast cancer incidence and survivalQ36848913
ABO blood group and the risk of pancreatic cancerQ37131928
Comprehensive handbook for developing a bladder cancer cystectomy databaseQ37953115
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladderQ38037276
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysisQ43625088
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.Q44793009
Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC).Q45084644
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomyQ46165799
Relationship between blood groups and tumour grade, number, size, stage, recurrence and survival in patients with transitional cell carcinoma of the bladderQ47401730
ABO blood group and risk of renal cell cancer.Q55144611
ABO blood groups and bladder carcinomaQ68841708
Role of blood groups as prognostic factors in primary breast cancerQ68846205
Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological studyQ68859402
Influence of blood group type on the natural history of superficial bladder cancerQ69403406
Relationship of blood groups and bladder cancerQ69991102
Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancerQ70335902
Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancerQ70521414
Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumorsQ74323839
P433issue5
P921main subjectRadical cystectomyQ111329312
P304page(s)625-630
P577publication date2014-02-02
P1433published inUrologic OncologyQ2113446
P1476titleEffect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy
P478volume32

Reverse relations

cites work (P2860)
Q52569036A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
Q64966406ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.
Q50225627Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Q36176989Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis
Q55000620Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
Q41056921Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent
Q51487533Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
Q50943065Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy.
Q41432872The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy
Q48007072The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
Q49407223The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients
Q53574858The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.
Q38901440The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder
Q26775411The prognostic value of ABO blood group in cancer patients
Q53185271Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.
Q89017427Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy

Search more.